Page URL:

Half of all IVF embryos could have genetic errors

20 October 2005
By BioNews
Appeared in BioNews 331

Around half of all the eggs produced by both older and younger women could have genetic errors, three new US studies suggest. The findings, reported at the annual meeting of the American Society for Reproductive Medicine (ASRM) in Montreal, Canada, have lead to calls from some fertility experts to screen all embryos used in IVF procedures. Carrying out such 'aneuploidy' screening routinely for all women undergoing fertility treatment would improve success rates, they claim. However, others urge caution until more is known about the potential benefits and harms of the technique.

Aneuploidy, or PGS (preimplantation genetic screening) involves removing a single cell from an embryo to check for chromosome errors that could affect normal development. It is different from PGD, (preimplantation genetic diagnosis) in which an embryo is tested for a single genetic disorder. The Human Fertilisation and Embryology Authority (HFEA) first licensed PGS in 2002, and the first reported UK birth following the use of this technique was in 2003.

The HFEA recommends that the technique is only appropriate for women aged over 35 who have undergone many failed IVF attempts, or those who have had several miscarriages. Both can be caused by aneuploidy in the early embryo, the rate of which is thought to increase as eggs age. However, the latest research suggests that about half the embryos produced using eggs from younger women could also be aneuploid.

Researchers at the Shady Grove Center for Preimplantation Genetics in Maryland looked at 275 embryos created using eggs from donors aged between 21 and 31, and found that about half of them had chromosome abnormalities. In another study, a team based at the Huntington Reproductive Centre in California looked at 289 embryos created using eggs from 22 donors under the age of 30, and found that around 42 per cent were aneuploid. Team leader Jeffrey Nelson said the results suggested that PGS should be more widely used. However, the study also revealed a wide variation in the proportion of eggs from each woman that was defective - ranging from 29 per cent to 83 per cent.

A third study, carried out by scientists at Reproductive Biology Associates in Atlanta, compared the rates of aneuploidy between women aged under 35, and those over 38. They found chromosome abnormalities in nearly two-thirds of the embryos produced using eggs from younger women, and in three-quarters of those from older women. Team leader Peter Nagy called the results 'a rewriting' of the textbooks, adding 'these defects should not be present in such a high proportion of patients'. However, none of the studies investigated the possibility that the abnormalities could have originated from the sperm used to create the embryos, or whether the drugs used to obtain eggs for IVF treatment could increase the risk of such errors.

UK expert and British Fertility Society spokesman Stuart Lavery called the findings 'interesting but preliminary', and cautioned against the introduction of widespread embryo screening, because PGS is still a relatively new technique. He told the BBC news website that Belgian researchers are currently carrying out a trial to compare the outcome of IVF treatment both with and without PGS, in young women.

A spokesman for the HFEA said that its expert group would monitor the development of the recent findings, and would listen to the UK's professional bodies if they felt the guidance for PGS should include more groups of women. 'We are concerned that women are properly aware of the potential risks before they choose to have this test and that women and embryos are not tested unnecessarily', he said.

IVF defects higher than expected
BBC News Online |  19 October 2005
Screening test 'would give hope to childless couples'
The Daily Telegraph |  19 October 2005
Young women have flawed eggs too
New Scientist |  18 October 2005
4 August 2008 - by Dr Rebecca Robey 
The increased risk of complications during pregnancy and at birth observed in babies conceived through assisted reproductive technology (ART) may be the result of parent's underlying infertility problems rather than the technology itself, a new study has revealed. In a report published in The Lancet, researchers found...
16 June 2008 - by Alison Cranage 
The British Fertility Society (BFS) has issued new guidelines for the use of pre-implantation genetic screening (PGS) in patients undergoing fertility treatment. The new guidelines, published in the journal Human Fertility, state that there is no evidence that PGS improves pregnancy rates or decreases miscarriage rates for...
16 February 2007 - by MacKenna Roberts 
Contrary to some earlier findings, a large Canadian study links an increase in birth defects with babies born through fertility treatments. According to the results of the study, which was presented at a Society for Maternal-Fetal Medicine meeting in San Francisco, the overall risk appears minimal - less...
2 December 2005 - by BioNews 
One of the key obstacles to getting human embryonic stem (ES) cell therapies 'from the bench to the bedside' has been overcome, according to UK researcher Roger Pedersen of the University of Cambridge. Speaking at the Human Fertilisation and Embryology Authority (HFEA)'s annual research conference, Professor Pederson said that...
23 May 2005 - by BioNews 
Testing embryos for chromosomal abnormalities before they are returned to the womb can dramatically improve the 'take home baby rate' for some patients, according to a US fertility doctor. Speaking at the Sixth International Symposium on Preimplantation Genetics, held in London last week, Yury Verlinsky of the Reproductive Genetics Institute...
4 April 2005 - by BioNews 
Experts in clinical genetics and assisted reproduction met last week to discuss issues that affect both areas of medicine, such as embryo testing, genetic causes of infertility, possible long term effects of assisted reproduction techniques, counselling concerns and European regulations. The workshop, held at the Institute for Prospective Technological Studies...
5 August 2003 - by BioNews 
An embryo screening technique that was licensed by the UK's Human Fertilisation and Embryology Authority (HFEA) in September 2002 has resulted in its first live birth in the UK. The procedure, aneuploidy screening, enables embryos to be tested for a range of chromosomal abnormalities and helps fertility doctors decide which...
18 June 2003 - by BioNews 
An embryo screening technique that was licensed by the UK's Human Fertilisation and Embryology Authority (HFEA) last September has resulted in its first pregnancy in the UK. Two UK clinics were initially given licences to perform aneuploidy screening: CARE in the Park, Nottingham and the Assisted Reproduction and Gynaecology Centre...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.